Prenatal determination of osteogenesis imperfecta is done by –
**Core Concept**
Osteogenesis imperfecta (OI) is a genetic disorder characterized by brittle bones, skeletal deformities, and often, blue sclerae. The condition is caused by mutations in the COL1A1 or COL1A2 genes, which encode for the alpha chains of type I collagen.
**Why the Correct Answer is Right**
Prenatal determination of osteogenesis imperfecta is crucial for families with a history of the condition. The correct answer is based on the fact that the condition can be diagnosed prenatally through ultrasound and biochemical tests. Specifically, a decrease in the levels of type I collagen in the amniotic fluid, as detected by assays such as the pNCP (pyridinoline cross-linked carboxyterminal telopeptide) test, can indicate the presence of osteogenesis imperfecta. This test measures the levels of cross-linked carboxyterminal telopeptide (CITP) in the amniotic fluid, which is a marker of type I collagen degradation.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not relevant to the prenatal diagnosis of osteogenesis imperfecta.
* **Option B:** While ultrasound can detect skeletal abnormalities, it is not a specific test for osteogenesis imperfecta.
* **Option C:** This option is not accurate, as the condition cannot be diagnosed solely through maternal serum screening.
**Clinical Pearl / High-Yield Fact**
In cases of osteogenesis imperfecta, the blue sclerae are due to the transparency of the sclera, which allows the underlying collagen fibers to be visible.
**Correct Answer: B. Ultrasound.**